Jasmine H. Francis, MD
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Eye (ocular) cancers and conditions
- Retinoblastoma
- Erdheim-Chester disease (ECD)
Get to Know Me
I am a board-certified ophthalmologist with specialty training in ophthalmic oncology: the care of people with cancers in, on, and around the eye. I understand the impact that cancer can have on our patients and their families. My goal is to provide the best treatment for each patient with the fewest side effects.
At Memorial Sloan Kettering, we have the advantage of working closely with a team of specialized doctors such as radiation oncologists, medical oncologists, pathologists, neurologists, and pediatric oncologists to create a coordinated plan of care for our patients.
As a member of the MSK Kids team, I care for young patients with retinoblastoma, a pediatric cancer that arises inside the eye. The treatment of retinoblastoma is particularly challenging because we are striving to successfully treat the disease while also maintaining the health and vision of the eyes. We take a team approach to achieve these goals to the best of our abilities.
I also participate in an interdisciplinary effort at Memorial Sloan Kettering to treat and study patients with histiocytic disorders such as Erdheim-Chester disease and Langerhans cell histiocytosis. These are systemic diseases that can also affect the eye. I offer a perspective of the disease as it relates to the eye, including any side effects on the eye during treatment.
As a clinician-scientist (academic oncologist), I have published numerous peer-reviewed papers and book chapters. My principle areas of research include intraocular tumors, including retinoblastoma and uveal melanoma. In addition, I continue to conduct research on the ocular side effects of cancer treatment. I was granted an Achievement Award by the American Academy of Ophthalmology, and was recognized as one of the Top 40 Under 40 in Ophthalmology (published by The Ophthalmologist) and in Cancer (by McGivney Global Advisor, the Lynk group). I received research funding from the Macula Society.
I graduated Magna Cum Laude, Phi Beta Kappa with honors from Columbia University. I was awarded a Research Fellowship Award, in addition to spending a year at Oxford University. During my training at New York University School of Medicine, I chose ophthalmology and after a transitional year, pursued an internship at Memorial Sloan Kettering Cancer Center. I completed my ophthalmology residency at the New York Eye and Ear Infirmary, where I was awarded the William J. & Judith Turner Outstanding Resident Award. I then returned to Memorial Sloan Kettering to complete my specialty training and fellowship in ophthalmic oncology, which is where I have remained.
I'm an ophthalmic (of-THAL-mik) oncologist, which is a cancer doctor with special training in eye cancers. This includes eye melanoma and retinoblastoma.
- Attending Surgeon
Conditions I Treat
- Eye (ocular) cancers and conditions
- Retinoblastoma
- Erdheim-Chester disease (ECD)
- Langerhans cell histiocytosis (LCH)
- Melanoma
Education
- MD, New York University School of Medicine
Residencies
- Ophthalmology - New York Eye and Ear Infirmary
Fellowships
- Ophthalmic Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Ophthalmology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
State Government
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Francis sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Francis’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jasmine H. Francis discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].